Nanotechnology-enabled tissue engineering is receiving increasing attention. The ultimate goal of tissue engineering as a medical treatment concept is to replace or restore the anatomic structure and function of damaged, injured, or missing tissue. At the core of tissue engineering is the construction of three-dimensional scaffolds out of biomaterials to provide mechanical support and guide cell growth into new tissues or organs. Biomaterials can be variously permanent or biodegradable, naturally occurring or synthetic, but inevitably need to be biocompatible. Using nanotechnology, biomaterial scaffolds can be manipulated at atomic, molecular, and macromolecular levels. Creating tissue engineering scaffolds in nanoscale also may bring unpredictable new properties to the material, such as mechanical (stronger), physical (lighter and more porous) or chemical reactivity (more active or less corrosive), which are unavailable at micro- or macroscales. For bone tissue engineering, a special subset of osteoinductive, osteoconductive, integrative and mechanically compatible materials are required. Such materials need to provide cell anchorage sites, mechanical stability, structural guidance and an in vivo milieu. Moreover, they need to provide an interface able to respond to local physiological and biological changes and to remodel the extracellular matrix (ECM) in order to integrate with the surrounding native tissue. Scientists in Singapore have developed a new nanoscale biocomposite that brings researchers one step closer to mimicking the architecture of the ECM.
Carbon nanotubes (CNTs) belong to the most exciting nanomaterials discovered so far and the buzz associated with them has to do with their amazing properties. Depending on their structure, they can be metals or semiconductors. They exhibit extraordinary mechanical properties, which make them extremely strong materials with good thermal conductivity. Their tensile strength is several times that of steel. These characteristics have generated strong interest in their possible use in reinforced composites, nanoelectronics, nanomechanical devices, circuits and computers. Single-wall nanotubes (SWNTs) are an intriguing variant of carbon nanotubes because they exhibit important electrical properties that are not shared by the multi-walled carbon nanotubes (MWNT). SWNTs are the most likely candidate for miniaturizing electronics toward the nanoscale. Because of their enormous commercial potential, universities, start-ups, and corporations have aggressively sought patent protection on nanotube-based products. A recent legal paper identifies key patents claiming compositions of matter, methods of production, and products incorporating nanotubes. The authors summarize potential patent invalidity arguments that may be raised against certain patents in the field and explain how the patent landscape impacts the commercialization of nanotube-based products. A proposed "Nanotube Patent Forum" could be a means for industry to facilitate cost-effective licensing transactions between patent holders and manufacturers.
The potential benefits of Nanofoods - foods produced using nanotechnology - are astonishing. Advocates of the technology promise improved food processing, packaging and safety; enhanced flavor and nutrition; 'functional foods' where everyday foods carry medicines and supplements, and increased production and cost-effectiveness. In a world where thousands of people starve each day, increased production alone is enough to warrant worldwide support. For the past few years, the food industry has been investing millions of dollars in nanotechnology research and development. Some of the world's largest food manufacturers, including Nestle, Altria, H.J. Heinz and Unilever, are blazing the trail, while hundreds of smaller companies follow their lead. Yet, despite the potential benefits, compared with other nanotechnology arenas, nanofoods don't get a lot of publicity. The ongoing debate over nanofood safety and regulations has slowed the introduction of nanofood products, but research and development continue to thrive - though, interestingly, most of the larger companies are keeping their activities quiet (when you search for the term 'nano' or nanotechnology' on the websites of Kraft, Nestle, Heinz and Altria you get exactly zero results). Although the risks associated with nanotechnology in other areas, such as cosmetics and medicine, are equally blurry, it seems the difference is that the public is far less apt to jump on the nanotechnology bandwagon when it comes to their food supply.
As their name suggests, nerve agents attack the nervous system of the human body. All such agents function the same way: by interrupting the breakdown of the neurotransmitters that signal muscles to contract, preventing them from relaxing. Nerve agents, depending on their purity, are clear and colorless or slightly colored liquids and may have no odor or a faint, sweetish smell. They evaporate at various rates and are denser than air, so they accumulate in low areas. Nerve agents include tabun(GA), sarin(GB), soman(GD), and VX. The military has a number of devices to detect nerve agent vapor and liquid. Current methods to detect nerve agents include surface acoustic wave (SAW) sensors, conducting polymer arrays, vector machines, and the most simple, color change paper sensors. Most of these systems have have certain limitations including low sensitivity and slow response times. By using readily synthesized network films of single-walled carbon nanotube bundles researchers have built a sensor capable of detecting G-series nerve agents such as Soman and Sarin (Sarin was used in the Tokyo subway terrorist attack in 1995). This research opens new opportunities in the design of real-time chemical warfare agent (CWA) sensors with independent response signatures.
Micro-and/or nano-electromechanical systems (MEMS/NEMS) are the basis of future nanotechnology, because they combine miniature sensors and actuators with electronics. The selection of appropriate materials for MEMS/NEMS fabrication is based on the careful consideration of a material's properties with regard to its intended application. For example, many MEMS devices, such as pressure, chemical and bio sensors, rely on actuation of a membrane structure and require a high fracture toughness material for the enhanced durability and shock resistance. On the other hand, for fabrication of controlled nanostructures, the material should be machinable up to atomic level. Currently, the materials used for MEMS/NEMS fabrication are based on silicon or oxides, which are brittle and have size effects such as lattice defects, anisotropy, grains and grain boundaries. These effects are the limiting factors in the reduction of pattern size, especially when a dimension of the pattern approaches a few tenths of a nanometer. Researchers in Japan now have introduced zirconium-based glass thin films for the fabrication of 3D micro- and nanostructures. These materials exhibit excellent micro/nano-formability under very low stresses, and are expected to become one of the most useful materials for fabricating NEMS/MEMS devices.
There seem to be an increasing number of websites, articles and investment reports that push, some might say hype, nanotechnology stocks as the next stock market super growth area. On the other hand, some investors are wary of a nanotechnology boom, where too much money chases too few listed companies, turning into a dot.com-like bust. Hype usually involves a bit of underlying truth about a trend but says nothing about whether something is going to be a good investment. As the International Herald Tribune put it: "While nanotechnology is spurring a revolution in electronics and medicine, investors seeking to benefit may need a lot of luck, as they did during the Internet bubble of the 1990s." The current interest in nanotech stocks is driven by the many advances that nanoscience and nanotechnology promise. The commercial realization of most of these promises lies in the (some say near, some say distant) future; things like quantum computing, molecular electronics, or lab-on-a chip medicine. In its current state, nanotechnology to a large degree takes place in labs and there is only a trickle of products coming to the market. All of these products are incremental improvements of existing products - scratch-resistant paint, better engine oil, antimicrobial household products, smaller chips, improved cosmetics, etc. What we are seeing right now is the beginning of a large technological trend and a stock buyer has to understand the difference between the many promises of nano- technologies, the research taking place today, and the actual contribution of nanotechnologies to commercial products. Let's look at a few facts that might give some perspective on what investing in nanotechnology stocks today is about - how has the market performed so far? what exactly is a "nanotechnology stock"? and the issue with these trillion dollar market size forecasts.
The precise positioning of nanoparticles on surfaces is key to most nano- technology applications especially molecular electronics. However, for automated patterning of particles, existing methods are either slow (e.g., dip-pen lithography) or require prefabricated patterns (e.g., by electrostatic positioning or by successive self-assembly, transfer, and integration). Moreover, the sorting of differently sized particles, organelles, and cells in microfluidic networks is important for many biological and medical applications. Purely size-based sorting would offer the greatest control, but an automated method so far does not exist. Researchers in Switzerland now have discovered that acoustic streaming leads to sorting of particles dependent on their size. Nanoparticles aggregate at the antinodes and micrometer-sized particles aggregate on the nodes of oscillation patterns on micro- machined cantilevers. These surprising results open new possibilities for the sorting of nanoparticles.
Hyperthermia therapy, a form of cancer treatment with elevated temperature in the range of 41-45C, has been recently paid considerable attention because it is expected to significantly reduce clinical side effects compared to chemotherapy and radiotherapy and can be effectively used for killing localized or deeply seated cancer tumors. Accordingly, various forms of hyperthermia have been intensively developed for the past few decades to provide cancer clinics with more effective and advanced cancer therapy techniques. However, in spite of the enormous efforts, all the hyperthermia techniques introduced so far were found to be not effective for completely treating cancer tumors. The low heating temperature owing to the heat loss through a relatively big space gap formed between targeted cells and hyperthermia agents caused by the hard to control agent transport, as well as killing healthy cells attributed to the difficulties of cell differentiations by hyperthermia agents, are considered as the main responsibilities for the undesirable achievements. In a possible breakthrough, researchers in Singapore now report the very promising and successful self-heating temperature rising characteristics of NiFe2O4 nanoparticles. Different from conventional magnetic hyperthermia, in-vivo magnetic nanoparticle hyperthermia is expected to be one of the best solutions for killing tumor cells which are deeply seated and localized inside the human body.